Table 1. Patient data before and after successful smoking cessation (N = 50).
| Baseline | After 3 months | After 1 year | P-value |
P-value |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Overall | 0–3M | 3M–1Y | 0M–1Y | ||||||
| BMI (kg/m2) | 22.8 [21.0, 23.4] | 23.0 [21.2, 24.2] | 23.8 [21.9, 25.0] | 0.001 | a | 0.046 | 0.028 | 0.013 | c |
| WC (cm) | 85.9 ± 9.0 | 87.6 ± 8.9 | 89.2 ± 8.4 | < 0.001 | b | < 0.001 | 0.019 | < 0.001 | d |
| SBP (mmHg) | 131 ± 17 | 128 ± 18 | 129.5 ± 18.7 | 0.244 | b | 0.085 | 0.434 | 0.386 | d |
| DBP (mmHg) | 76 ± 10 | 75 ± 10 | 76 ± 11 | 0.434 | b | 0.117 | 0.329 | 0.893 | d |
| HbA1c (%) | 5.8 [5.6, 6.6] | 5.9 [5.6, 6.7] | 5.9 [5.6, 7.0] | 0.206 | a | 0.361 | 0.188 | 0.052 | c |
| LDL-C (mg/dl) | 112 ± 29 | 119 ± 36 | 114 ± 34 | 0.187 | b | 0.093 | 0.166 | 0.595 | d |
| HDL-C (mg/dl) | 55.3 ± 14.2 | 58.4 ± 17.2 | 56.3 ± 16.4 | 0.095 | b | 0.047 | 0.106 | 0.508 | d |
| TG (mg/dl) | 148 ± 64 | 187 ± 97 | 178 ± 93 | 0.013 | b | 0.010 | 0.547 | 0.022 | d |
| AT-LDL (µg/ml) | 1.8 [1.4, 2.2] | 1.8 [1.4, 2.1] | 1.5 [1.1, 1.9] | < 0.001 | a | 0.177 | 0.006 | < 0.001 | c |
| SAA-LDL (µg/ml) | 9.0 [6.0, 13.0] | 9.0 [6.0, 12.0] | 7.5 [4.0, 10.0] | 0.010 | a | 0.280 | 0.008 | 0.014 | c |
| hsCRP (mg/dL) | 0.6 [0.3, 2.0] | 1.0 [0.3, 2.7] | 1.1 [0.4, 1.9] | 0.408 | a | 0.357 | 0.364 | 0.365 | c |
Data are presented as the mean ± standard deviation or median [interquartile range]
p-value: a, Friedman Test; b, One-way repeated measures ANOVA; c, Wilcoxon signed rank test; d, paired t-test
0–3M, baseline vs 3 months; 3M–1Y, 3 months vs 1 year; 0M–1Y, baseline vs 1 year; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressures; DBP, diastolic blood pressures; HbA1c, hemoglobin A1c; ; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; SAA-LDL, serum amyloid A-LDL; AT-LDL, α-antitrypsin – low-density lipoprotein; hsCRP; high sensitivity C-reactive protein